11月25日，钱江生化涨5.08%，截至发稿，报6.41元/股，成交5530.66万元，换手率2.84%，总市值55.55 亿元。 从基金十大重仓股角度 责任编辑：小浪快报 民生加银国证2000指数增强A（019814）基金经理为何江。 截至发稿，何江累计任职时间14年189天，现任基金资产总规模8.64亿元，任职期间最佳基金回报 57.31%， 任职期间最差基金回报-49.3%。 资料显示，浙江钱江生物化学股份有限公司位于浙江省海宁市海洲街道钱江西路178号钱江大厦，成立 日期1993年10月28日，上市日期1997年4月8日，公司主营业务涉及环保综合治理、生物制造及热电业 务。从事的主要业务包括环保工程业务、固废医废危废处置业务、污水处理业务及自来水制水业务。从 事植物生长调节剂、杀虫剂、杀菌剂为主的生物农药产品的研发、生产和销售。从事发电供热业务。主 营业务收入构成为：污水处理29.75%，工程施工21.08%，废弃物清运及处置19.04%，生物制品 18.06%，自来水供应6.70%，热电供应4.51%，其他(补充)0.49%，其他0.38%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发 ...

11月21日，长青股份跌5%，截至发稿，报6.08元/股，成交5723.07万元，换手率1.99%，总市值39.50亿 元。长青股份股价已经连续3天下跌，区间累计跌幅4.62%。 资料显示，江苏长青农化股份有限公司位于江苏省扬州市江都区文昌东路1006号，成立日期2001年1月4 日，上市日期2010年4月16日，公司主营业务涉及化学农药的生产、销售,目前产品包括除草剂、杀虫 剂、杀菌剂等三大系列共18种原药、69种制剂。主营业务收入构成为：除草剂50.88%，杀虫剂 37.75%，杀菌剂8.34%，服务业1.77%，其他0.87%，调节剂0.39%。 从基金十大重仓股角度 霍顺朝累计任职时间2年227天，现任基金资产总规模162.51亿元，任职期间最佳基金回报30.93%， 任 职期间最差基金回报0.48%。 叶天垚累计任职时间227天，现任基金资产总规模21.96亿元，任职期间最佳基金回报2.97%， 任职期间 最差基金回报0.05%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 ...

多年攻坚下，他攻克11步反应的复杂合成路线难题，研发的除草剂、杀虫剂、杀菌剂等 农药品类，被完整保存在办公室电脑里。通过与山东、江苏、湖北等地企业深度合作，他成 功将国外优质农药的生产工艺本土化，推动多项技术实现产业化，打破了大众对农药"高毒 低效"的固有偏见。 从阳离子光引发剂到低毒高效农药，从3000元小项目到3000万大业绩，从实验室到生产 线，刘安昌用二十年坚守践行着科研工作者的使命。如今，已届花甲的他仍奋战在科研一 线，谈及未来，他表示团队将持续迭代技术成果，让更多实验室里的创新突破，成为赋能地 方经济发展的坚实力量。 编辑：熊展平 这份"让科研落地"的初心，早在2000年就已扎根。彼时还在华中科技大学读博的刘安 昌，一篇科研论文被苏州一家农药企业关注，随后促成了一笔3000元的小型合作。"看着自 己的研究能造福社会，那种成就感无可替代。"正是这次经历，让他坚定了"科研要对接市场 需求"的方向。 科研之路从非一帆风顺，却总有诚意与坚持照亮前路。2008年冬天，刘安昌与温州一家 企业负责人约定洽谈合作，突遇大雪导致火车停运，对方竟辗转乘船赶往他的江西老家赴 约。这份赤诚让刘安昌深受触动，也让他在农药领 ...

Core Viewpoint - Runfeng Co., Ltd. has shown a mixed performance in terms of stock trading and financial results, with significant growth in revenue and net profit, but a decline in stock price and net buying in margin trading [1][2]. Group 1: Stock Performance - On November 14, Runfeng Co., Ltd. experienced a stock price decline of 1.24%, with a trading volume of 55.46 million yuan [1]. - The margin trading data indicates a net margin buy of -0.93 million yuan on the same day, with a total margin balance of 1.87 billion yuan [1]. - The current margin balance of 1.86 billion yuan represents 0.92% of the circulating market value, which is above the 50th percentile level over the past year, indicating a relatively high level [1]. Group 2: Financial Performance - For the period from January to September 2025, Runfeng Co., Ltd. achieved a revenue of 10.91 billion yuan, reflecting a year-on-year growth of 11.51% [2]. - The net profit attributable to the parent company for the same period was 890 million yuan, showing a substantial year-on-year increase of 160.49% [2]. Group 3: Shareholder and Dividend Information - Since its A-share listing, Runfeng Co., Ltd. has distributed a total of 1.37 billion yuan in dividends, with 992 million yuan distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders decreased by 2.90% to 6,630, while the average circulating shares per person increased by 2.99% to 42,284 shares [2][3]. - Among the top ten circulating shareholders, several institutions have adjusted their holdings, with notable decreases in shares held by some funds [3].

Core Viewpoint - Jiangshan Co., Ltd. has shown a significant increase in stock price this year, with a 70.50% rise, despite a slight decline in recent trading days [1][2]. Financial Performance - For the period from January to September 2025, Jiangshan Co., Ltd. achieved a revenue of 4.516 billion yuan, representing a year-on-year growth of 5.20% [2]. - The net profit attributable to shareholders for the same period was 425 million yuan, marking a substantial increase of 147.91% year-on-year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 9.05% to 19,100, while the average circulating shares per person increased by 9.95% to 22,509 shares [2]. - The company has distributed a total of 2.693 billion yuan in dividends since its A-share listing, with 384 million yuan distributed over the past three years [3]. Stock Market Activity - On November 14, Jiangshan Co., Ltd. saw its stock price rise by 2.11%, reaching 23.70 yuan per share, with a trading volume of approximately 93.08 million yuan [1]. - The company’s market capitalization stands at 10.206 billion yuan, with a turnover rate of 0.93% [1]. Business Overview - Jiangshan Co., Ltd. primarily engages in the research, production, and sales of agricultural chemicals, including herbicides and insecticides, as well as chemical products and new materials [1]. - The revenue composition of the company includes 61.85% from agricultural products, 14.05% from chemical products, 13.95% from new materials, and 9.40% from thermal power products [1]. Institutional Holdings - As of September 30, 2025, major shareholders include China Europe Fund and Hong Kong Central Clearing Limited, with notable changes in their holdings [3].

Core Insights - Jiangshan Chemical achieved a revenue of 4.516 billion yuan in the first nine months of 2025, representing a year-on-year growth of 5.20% [1] - The net profit attributable to shareholders reached 425 million yuan, showing a significant increase of 147.91% year-on-year [1] - The company reported a net profit of 335 million yuan after deducting non-recurring gains and losses, which is a year-on-year growth of 103.62% [1] Financial Performance - For the first nine months, the production volumes of herbicides, insecticides, and caustic soda were 69,200 tons, 18,100 tons, and 700,300 tons respectively [1] - Sales revenues for these products were 2.034 billion yuan, 554 million yuan, and 421 million yuan respectively [1] - In Q3 alone, Jiangshan Chemical generated a revenue of 1.157 billion yuan, marking a year-on-year increase of 2.75% [1] - The net profit for Q3 attributable to shareholders was 86.725 million yuan, reflecting a dramatic year-on-year growth of 11,890.01% [1] Strategic Initiatives - The company is focusing on precise marketing strategies and innovative sales models to drive revenue growth [2] - Jiangshan Chemical is actively pursuing cost reduction and efficiency improvements through optimized procurement management [2] - The company emphasizes technological innovation, enhancing resource conversion efficiency through process optimization and recycling [2] - Jiangshan Chemical aims to build a green, efficient, and sustainable competitive advantage while deepening its core business layout [2]

据江山股份财务总监黄海介绍，因草甘膦第三季度价格有所增长，公司第三季度草甘膦毛利率环比有所 上升。单季度来看，江山股份第三季度实现营业收入11.57亿元，同比增长2.75%;归属于上市公司股东 的净利润8672.53万元，同比增长11890.01%。 江山股份董事长王利表示："报告期内，公司坚持精准营销策略，创新营销策略和模式，销售收入同比 实现增长;持续推进降本增效，优化采购管理体系，采购降本效果显著;坚持技术革新，通过工艺优化、 循环利用等提升资源转化效率，实现原料、能源降耗降本。公司将坚定围绕既定发展战略，持续深化核 心业务布局，构建绿色、高效、可持续的竞争力。" (陆瑰) 中化新网讯 11月5日，南通江山农药化工股份有限公司(以下简称江山股份)召开2025年第三季度业绩说 明会。 数据显示，今年前9个月，江山股份除草剂、杀虫剂、氯碱等产品的产量分别为6.92万吨、1.81万吨、 70.03万吨，销售金额分别为20.34亿元、5.54亿元、4.21亿元。2025年前三季度，江山股份实现营业收入 45.16亿元，同比增长5.20%;归属于上市公司股东的净利润4.25亿元，同比增长147.91%;归属于上市 ...

Core Viewpoint - Jiangshan Co., Ltd. has experienced a stock price increase of 67.84% year-to-date, but recent trading shows a decline of 2.02% on November 12, with a market capitalization of 10.047 billion yuan [1] Financial Performance - For the period from January to September 2025, Jiangshan Co., Ltd. achieved a revenue of 4.516 billion yuan, representing a year-on-year growth of 5.20%, while the net profit attributable to shareholders increased by 147.91% to 425 million yuan [2] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 9.05% to 19,100, with an average of 22,509 circulating shares per shareholder, an increase of 9.95% [2] - The company has distributed a total of 2.693 billion yuan in dividends since its A-share listing, with 384 million yuan distributed over the past three years [3] Stockholder Composition - Among the top ten circulating shareholders, China Europe Times Pioneer Stock A holds 13 million shares, remaining unchanged, while Hong Kong Central Clearing Limited reduced its holdings by 662,000 shares to 4.667 million shares [3] - New shareholder Penghua China 50 Mixed Fund holds 3.130 million shares, while Xingquan Huan Yuan Two-Year Holding Mixed Fund has exited the top ten circulating shareholders [3] Business Overview - Jiangshan Co., Ltd. primarily engages in the research, production, and sales of pesticide products (61.85% of revenue), chemical products (14.05%), new materials (13.95%), and thermal power products (9.40%) [1]

Core Viewpoint - Jiangsu Fengshan Group Co., Ltd. held a Q3 2025 earnings briefing on November 11, 2025, to discuss its financial performance and address investor inquiries [1][2]. Group 1: Earnings Performance - For the first three quarters of 2025, the company achieved a revenue of 914 million yuan, representing a year-on-year increase of 14.29% [3]. - The net profit attributable to shareholders was 42 million yuan, showing a significant year-on-year growth of 271.03%, primarily due to an increase in product gross margins [3]. Group 2: Accounts Receivable Management - The company has enhanced its customer credit evaluation system and strengthened accounts receivable management, focusing on both preventive measures and multi-dimensional collection strategies [4]. - A tripartite mechanism involving business, market, and legal departments has been established to improve the collection process [4]. Group 3: Operational Insights - The company reported strong operational performance across its pesticide, new energy electronic chemicals, and fine chemical new materials sectors, with detailed data available in the Q3 report [4]. - The capacity utilization rate for pesticide products remains high due to sufficient order volumes [4]. Group 4: Strategic Collaborations - The company has signed a technology development contract with Tsinghua University to leverage its research capabilities for advancing its new energy sector [5]. - This collaboration aims to enhance the company's R&D capabilities and market competitiveness in the new energy field [5]. Group 5: Product Margins and Competitive Strategy - The gross margins for herbicides and insecticides have increased compared to the previous year [6]. - The company plans to innovate in production processes and technology to improve product yield and reduce costs in its pesticide business, while also expanding its product lines in new materials and strengthening partnerships in the new energy sector [6]. Group 6: Shareholder Information - Information regarding the shareholding structure of the top ten shareholders is available in the Q3 report [6]. Group 7: Additional Information - Investors can access the details of the earnings briefing and its main content through the Value Online platform [7]. - The company expressed gratitude to investors for their participation and ongoing support [7].

Core Viewpoint - Jiangshan Co., Ltd. has shown a significant increase in stock price and profitability, indicating strong performance in the agricultural chemicals sector [1][2]. Company Overview - Jiangshan Co., Ltd. is primarily engaged in the research, production, and sales of agricultural products, particularly herbicides and insecticides, as well as chemical products, new materials, and steam from cogeneration [1]. - The company was established on October 18, 1990, and went public on January 10, 2001 [1]. Financial Performance - For the period from January to September 2025, Jiangshan Co., Ltd. achieved a revenue of 4.516 billion yuan, representing a year-on-year growth of 5.20% [2]. - The net profit attributable to shareholders for the same period was 425 million yuan, showing a remarkable year-on-year increase of 147.91% [2]. - The company has distributed a total of 2.693 billion yuan in dividends since its A-share listing, with 384 million yuan distributed over the past three years [2]. Stock Performance - As of November 7, Jiangshan Co., Ltd.'s stock price increased by 72.23% year-to-date, with a recent slight increase of 0.08% over the last five trading days [1]. - The stock's trading volume on November 7 was 81.092 million yuan, with a turnover rate of 0.80% [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 9.05% to 19,100, with an average of 22,509 circulating shares per person, an increase of 9.95% [2]. - Notable shareholders include China Europe Fund and Hong Kong Central Clearing Limited, with changes in their holdings compared to the previous period [2].